{
  "paper_id": "PMC10739705",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739705/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Quality of life in long-term survivors of different types of blood cancer at the time of the survey, as assessed by the EORTC QLQ C-30 (global health status, functioning, symptoms) and HADS questionnaires (depression). The results of the HADS anxiety scale (not shown) were similar to those of the depression scale. MGUS monoclonal gammopathy of undetermined significance, 16 responding survivors, MM multiple myeloma, 37 survivors, iNHL/CLL indolent non-Hodgkin lymphoma/chronic lymphocytic leukemia, 254 survivors, MPN/CML myeloproliferative neoplasm/chronic myeloid leukemia, 106 survivors, MDS myelodysplastic syndrome, 5 survivors, aNHL/HL aggressive non-Hodgkin lymphoma/Hodgkin lymphoma, 481 survivors, AML/ALL acute myeloid leukemia/acute lymphoblastic leukemia, 74 survivors, AlloTx allogeneic transplantation, 547 survivors. Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/b904d0cdada4/41598_2023_50289_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/b904d0cdada4/41598_2023_50289_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/b904d0cdada4/41598_2023_50289_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/b904d0cdada4/41598_2023_50289_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/b904d0cdada4/41598_2023_50289_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10739705/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/b904d0cdada4/41598_2023_50289_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Quality of life in long-term blood cancer survivors at the time of the survey in relation to the duration of follow-up, as assessed by the EORTC QLQ C-30 (global health status, functioning, symptoms) and HADS questionnaires (depression). The results of the HADS anxiety scale (not shown) were similar to those of the depression scale. Follow-up 4–5 years, 284 responding survivors; 6–10 years, 516 survivors; > 10 years, 720 survivors. Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/f2454a4f98ed/41598_2023_50289_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/f2454a4f98ed/41598_2023_50289_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/f2454a4f98ed/41598_2023_50289_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/f2454a4f98ed/41598_2023_50289_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/f2454a4f98ed/41598_2023_50289_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10739705/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93b/10739705/f2454a4f98ed/41598_2023_50289_Fig2_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Both before and after blood cancer diagnosis, the most frequent type was statutory insurance (72.2% [1108 of 1535 responding survivors] versus 71.0% [1087/1532]), followed by statutory insurance with private supplementation (12.7% [195/1535] versus 13.6% [209/1532]), full private insurance (9.2% [141/1535] versus 9.1% [140/1532]), and state subsidy (5.6% [89/1535] versus 6.0% [92/1532]).Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Overall well-being and spirituality\nQuality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Quality of life\nQuality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Quality of life significantly differed among disease groups, with best scores in AML/ALL, intermediate scores in aNHL/HL, iNHL/CLL, and AlloTx, and worst scores in MPN/CML (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Quality of life was similar among survivors followed up for 4–5, 6–10, or > 10 years (Fig. 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 2,
    "claims_count": 35,
    "images_downloaded": 2,
    "tables_filtered": 33
  }
}